Literature DB >> 31289857

Biphasic effects of 5-HT1A agonism on impulsive responding are dissociable from effects on anxiety in the variable consecutive number task.

Miranda L Groft1, Marigny C Normann1,2, Paige R Nicklas1, Julia E Jagielo-Miller1,3, Peter J McLaughlin4.   

Abstract

The serotonergic 5-HT1A receptor is known to be involved in both impulsivity and anxiety-related behavior. Although anxiety and impulsivity are different constructs, it has been shown that anxiogenesis can result in impulsiveness. It is therefore important to determine if the 5-HT1A receptor is involved in the commission of impulsive actions independent of its effects on anxiety. The 5-HT1A agonist 8-OH-DPAT (0.0125-0.1 mg/kg subcutaneous) increased impulsive action at low doses, but decreased it at higher doses, on the novel paced variable consecutive number with discriminative stimulus task (VCN). Neither the 5-HT1A antagonist WAY 100,635 (0.2-1.2 mg/kg subcutaneous), nor the noradrenergic antagonist and pharmacological stressor yohimbine (1-2 mg/kg intraperitoneal) altered measures of impulsivity. Stress induced by yohimbine was sufficient to produce anxiety-like behavior in the elevated zero maze, confirming that the VCN task is a selective assay of impulsive action that is not affected by anxiety. We hypothesize that the biphasic effect of 8-OH-DPAT is due to actions on presynaptic raphe 5-HT1A autoreceptors, and also postsynaptic 5-HT1A receptors. These results suggest that this receptor mediates impulsive action and that this is not secondary to its role in anxiety.

Entities:  

Keywords:  5-HT1A receptors; Anxiety; Norepinephrine; Operant; Serotonin; Stress

Year:  2019        PMID: 31289857     DOI: 10.1007/s00210-019-01684-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  42 in total

1.  Differential effects of cannabinoid CB1 inverse agonists and antagonists on impulsivity in male Sprague Dawley rats: identification of a possibly clinically relevant vulnerability involving the serotonin 5HT1A receptor.

Authors:  Peter J McLaughlin; Julia E Jagielo-Miller; Emily S Plyler; Kerry K Schutte; V Kiran Vemuri; Alexandros Makriyannis
Journal:  Psychopharmacology (Berl)       Date:  2017-02-01       Impact factor: 4.530

2.  Nucleus incertus contributes to an anxiogenic effect of buspirone in rats: Involvement of 5-HT1A receptors.

Authors:  Jigna Rajesh Kumar; Ramamoorthy Rajkumar; Liying Corinne Lee; Gavin S Dawe
Journal:  Neuropharmacology       Date:  2016-07-18       Impact factor: 5.250

3.  Acute effects of alprazolam on risky decision making in humans.

Authors:  Scott D Lane; Oleg V Tcheremissine; Lori M Lieving; Sylvain Nouvion; Don R Cherek
Journal:  Psychopharmacology (Berl)       Date:  2005-04-14       Impact factor: 4.530

4.  Dexfenfluramine and 8-OH-DPAT modulate impulsivity in a delay-of-reward paradigm: implications for a correspondence with alcohol consumption.

Authors:  Constantine X. Poulos; J.L. Parker; A.D. Le
Journal:  Behav Pharmacol       Date:  1996-08       Impact factor: 2.293

5.  Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide.

Authors:  Sylvie Lemonde; Gustavo Turecki; David Bakish; Lisheng Du; Pavel D Hrdina; Christopher D Bown; Adolfo Sequeira; Neena Kushwaha; Stephen J Morris; Ajoy Basak; Xiao-Ming Ou; Paul R Albert
Journal:  J Neurosci       Date:  2003-09-24       Impact factor: 6.167

6.  The pharmacology of impulsive behaviour in rats IV: the effects of selective serotonergic agents on a paced fixed consecutive number schedule.

Authors:  J L Evenden
Journal:  Psychopharmacology (Berl)       Date:  1998-12       Impact factor: 4.530

Review 7.  5-HT1A receptor ligands in animal models of anxiety, impulsivity and depression: multiple mechanisms of action?

Authors:  R Schreiber; J De Vry
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1993-01       Impact factor: 5.067

8.  Norepinephrine and impulsivity: effects of acute yohimbine.

Authors:  Alan C Swann; Marijn Lijffijt; Scott D Lane; Blake Cox; Joel L Steinberg; F Gerard Moeller
Journal:  Psychopharmacology (Berl)       Date:  2013-04-06       Impact factor: 4.530

Review 9.  Serotonin 5-HT1A receptors as targets for agents to treat psychiatric disorders: rationale and current status of research.

Authors:  Pau Celada; Analía Bortolozzi; Francesc Artigas
Journal:  CNS Drugs       Date:  2013-09       Impact factor: 5.749

10.  Differential effects of the pharmacological stressor yohimbine on impulsive decision making and response inhibition.

Authors:  M C Schippers; D Schetters; T J De Vries; T Pattij
Journal:  Psychopharmacology (Berl)       Date:  2016-06-01       Impact factor: 4.530

View more
  3 in total

1.  Multiple cholinesterase inhibitors have antidepressant-like properties in the mouse forced swim test.

Authors:  Paul J Fitzgerald; Pho J Hale; Anjesh Ghimire; Brendon O Watson
Journal:  Behav Brain Res       Date:  2021-04-25       Impact factor: 3.332

Review 2.  Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities.

Authors:  Paul J Fitzgerald; Pho J Hale; Anjesh Ghimire; Brendon O Watson
Journal:  Front Behav Neurosci       Date:  2021-01-14       Impact factor: 3.558

Review 3.  A Role for Serotonin in Modulating Opposing Drive and Brake Circuits of Impulsivity.

Authors:  Stephanie S Desrochers; Mitchell G Spring; Katherine M Nautiyal
Journal:  Front Behav Neurosci       Date:  2022-02-17       Impact factor: 3.558

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.